Recent studies have suggested that manipulating the tumor-associated macrophage phenotype is a valid therapeutic approach in cancer. In turn, these studies have given some insight into the factors that polarize macrophages, thereby suggesting alternative therapeutic avenues.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Regorafenib plus nivolumab in unresectable hepatocellular carcinoma: the phase 2 RENOBATE trial
Nature Medicine Open Access 19 February 2024
-
TIM-3 as a promising target for cancer immunotherapy in a wide range of tumors
Cancer Immunology, Immunotherapy Open Access 11 August 2023
-
Clinical significance and oncogenic function of NR1H4 in clear cell renal cell carcinoma
BMC Cancer Open Access 19 September 2022
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Katie Vicari / Nature Publishing Group
References
Noy, R. & Pollard, J.W. Immunity 41, 49–61 (2014).
Shand, F.H. et al. Proc. Natl. Acad. Sci. USA 111, 7771–7776 (2014).
Murray, P.J. et al. Immunity 41, 14–20 (2014).
Cavnar, M.J. et al. J. Exp. Med. 210, 2873–2886 (2013).
Franklin, R.A. et al. Science 344, 921–925 (2014).
Colegio, O.R. et al. Nature 513, 559–563 (2014).
Ugel, S. et al. Cell Rep. 2, 628–639 (2012).
Klug, F. et al. Cancer Cell 24, 589–602 (2013).
De Palma, M. & Lewis, C.E. Cancer Cell 23, 277–286 (2013).
Ruffell, B. et al. Cancer Cell 26, 623–637 (2014).
Cassier, P.A. et al. Cancer 118, 1649–1655 (2012).
Pyonteck, S.M. et al. Nat. Med. 19, 1264–1272 (2013).
Ries, C.H. et al. Cancer Cell 25, 846–859 (2014).
Shibata, Y. et al. Immunity 15, 557–567 (2001).
Sauter, K.A. et al. J. Leukoc. Biol. 96, 265–274 (2014).
Marigo, I. et al. Immunity 32, 790–802 (2010).
Sonda, N. et al. Immunity 38, 1236–1249 (2013).
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Bronte, V., Murray, P. Understanding Local Macrophage Phenotypes In Disease: Modulating macrophage function to treat cancer. Nat Med 21, 117–119 (2015). https://doi.org/10.1038/nm.3794
Published:
Issue Date:
DOI: https://doi.org/10.1038/nm.3794
This article is cited by
-
Regorafenib plus nivolumab in unresectable hepatocellular carcinoma: the phase 2 RENOBATE trial
Nature Medicine (2024)
-
TIM-3 as a promising target for cancer immunotherapy in a wide range of tumors
Cancer Immunology, Immunotherapy (2023)
-
A Redox-responsive Prodrug Nanogel of TLR7/8 Agonist for Improved Cancer Immunotherapy
Chinese Journal of Polymer Science (2023)
-
Interleukin-32γ promotes macrophage-mediated chemoresistance by inducing CSF1-dependent M2 macrophage polarization in multiple myeloma
Cancer Immunology, Immunotherapy (2023)
-
Modulation of the tumour microenvironment in hepatocellular carcinoma by tyrosine kinase inhibitors: from modulation to combination therapy targeting the microenvironment
Cancer Cell International (2022)
